Name & Company Information Location Interests Events
user-icon

Shruti Abbato

Celdara Medical, LLC

VP of Business Development

Lebanon

United States

Interest Area>Biologics, Interest Area>Partnering Celdara Medical, LLC Company Presentation
user-icon

Rebecca Abbott

March of Dimes

Director, Public Policy

Washington

United States

New Hope, Big Challenges: Newborn Screening in the Genetic Era
user-icon

Thierry Abribat

Successful ventures - CEOs testimonials from bioMérieux & Alizé Pharma 3
6023B15F-5FFA-47BA-8382-AACE4A28211C

Amesh Adalja

Johns Hopkins Center for Health Security

Senior Scholar

Interest Area>Infectious Diseases & Vaccines, Session Tracks>Infectious Disease And Vaccines Platform technologies: Powering Commercial and Outbreak Development
user-icon

Cyrus Agarabi

U.S. Food and Drug Administration

Principal Investigator/Research/Review Officer/CDR

Session Tracks>Regulatory Innovation Regulatory Interactions and Opportunities at the Forefront of Innovative Manufacturing
630953-23012079-898a-4c77-9380-033cb2306177

Dr. Ankit Agarwal

Imbed Biosciences Inc.

CEO

Madison

United States

Asia>China, Asia>India, Asia>Japan, Asia>South Korea, BioPharma/Human Health>Devices, BioPharma/Human Health>Drug Delivery, BioPharma/Human Health>Tissue Engineering, Exhibition Interest>BIO Member Services Zone, Exhibition Interest>BIO Partner Pavilion, Investor>Investment Banker, Investor>Venture Capital/Private Equity, Management Level>CEO/President/Principal/Founder, Management Level>Chief Officer, Management Level>Vice President/General Manager/Partner/Managing Director, North America>United States, Other>Australia, Other>New Zealand, Primary Role>Business Development, Primary Role>Manufacturing/Distribution/Operations, Primary Role>Marketing/Sales, Primary Role>Researcher/ Scientist, Primary Role>Venture Capitalist, Professional Services>Business Development, Professional Services>Contract Manufacturing, Professional Services>Contract Research Organization, Professional Services>Investment Bank, Professional Services>Investor Relations, Program Interest>Business Development & Finance, Program Interest>Emerging Opportunities In Global Markets, Program Interest>Next Generation Biotherapeutics, Program Interest>Regulatory Science, Program Interest>Translational Research, Program Interest>Value; Patient Access; & Commercialization, Therapeutic/Healthcare Interest>Chemicals, Therapeutic/Healthcare Interest>Dermatology, Therapeutic/Healthcare Interest>Pain Management, Therapeutic/Healthcare Interest>Regenerative Medicine, Therapeutic/Healthcare Interest>Tissue Engineering, Western Europe>France, Western Europe>Germany, Western Europe>Netherlands, Western Europe>Sweden, Western Europe>Switzerland, Western Europe>U.K., Interest Area, Interest Area>Business Development & Finance, Interest Area>Drug Delivery, Interest Area>Emerging Opportunities In Global Markets, Interest Area>Medical Devices, Interest Area>Nanotechnology, Interest Area>Opioids, Interest Area>Pain Management, Interest Area>Partnering, Interest Area>Regenerative Medicine, Interest Area>Tissue Engineering, Product Focus Zone/Special Pavilion, Product Focus Zone/Special Pavilion>Innovation Zone, Session Tracks, Session Tracks>Business Development & Finance, Session Tracks>Emerging Opportunities In Global Markets, Session Tracks>Opioids: Changing The Paradigm On Treating Pain And Addiction, Session Tracks>Regulatory Innovation, Session Tracks>Translational Research, Session Tracks>Value‚ Patient Access And Reimbursement Imbed Biosciences Inc. Start-Up Stadium
674213-cd4ce45f-ebb7-4016-9e15-1d10ba553380

Sonalee Agarwal

Alnylam Pharmaceuticals

VP Value Evidence & Strategy

Cambridge

United States

Interest Area>Business Development & Finance, Interest Area>CNS/Neurological, Interest Area>Central Nervous System, Interest Area>Diagnostics, Interest Area>Digital Health, Interest Area>Emerging Opportunities In Global Markets, Interest Area>Gene Editing, Interest Area>Gene/Cell Therapy, Interest Area>Genetic Disorders, Interest Area>Genomics, Interest Area>Neurological Disease, Interest Area>Orphan & Rare Diseases, Interest Area>Patient Advocacy, Interest Area>Pharmacogenomics, Product Focus Zone/Special Pavilion>BIO Member Services Pavilion, Session Tracks>Brain Health, Session Tracks>Business Development And Finance, Session Tracks>Digital Health, Session Tracks>Emerging Opportunities In Global Markets, Session Tracks>Genome Editing, Session Tracks>Oncology, Session Tracks>Orphan And Rare Diseases, Session Tracks>Patient Advocacy, Session Tracks>Value‚ Patient Access And Reimbursement Innovative Contracting in Cell and Gene Therapies in Europe
user-icon

Sam Agresta

Infinity Pharmaceuticals

Chief Medical Officer

Cambridge

United States

What Was Hot at ASCO 2019? Highlights from the World’s Biggest Oncology Meeting
user-icon

Dr. Andrew Aherrera

Cugene Inc.

Head of Business Development

Waltham

United States

Cugene Inc. Company Presentation
user-icon

Mr. Jaeyoung Ahn

VORONOI Inc.

Head of BD

Incheon

Korea, Republic of

VORONOI Inc. Company Presentation
545055-9fecb268-4303-4a8a-bf1c-dfb208ec3e81

Murray Aitken

IQVIA Institute for Human Data Science

Executive Director

New York

United States

Biotech’s Contribution to Innovation: Current and Future Drivers of Success, Closing the Innovation Gap in Rare Diseases: Where are we Headed?
674569-59feee58-199f-49f1-a57e-47bbc897b724

Nsikan Akpan

PBS Newshour

Digital Science Producer, PBS News Hour

Falling in Love with Science: Championing Science for Everyone, Everywhere
user-icon

Amirah Al Idrus

FierceBiotech

Editor

Washington

United States

How Could AI Help Cure Cancer in the Next Five Years?
544193-07f79335-d052-4d7b-9d3f-764423bf635c

Dr. Wendy Alderton

Cambridge University, UK

Cancer Research UK Cambridge Centre Early Detection Programme Manager

Cambridge

United Kingdom

Interest Area>Molecular Diagnostics, Interest Area>Oncology, Interest Area>Translational Research, Session Tracks>Oncology Climbing Cancer’s North Face: The Challenges of Developing and Clinically Validating Biomarkers for Early Cancer Detection
666561-4dca1426-3575-4b25-9353-defd469fb2b9

Ron Alfa

Recursion Pharmaceuticals

Senior Vice President, Translational Discovery

Salt Lake City

United States

Power of AI/ML in Biopharma Drug Discovery and Development
Alferman_1443_2

Jim Alferman

Sekisui

Associate Director, Business Development

St. Louis

United States

Diagnostics/Device/Digital Health>Drug Delivery Device, Diagnostics/Device/Digital Health>Molecular/Cellular Diagnostics, Diagnostics/Device/Digital Health>Non-Molecular Diagnostics, Drug>Clinical, Drug>Market - Drug (on Patent), Drug>Market - Generics/OTC, Drug>Preclinical, Interest Area>Biologics, Interest Area>Biomanufacturing, Interest Area>Diagnostics, Interest Area>Molecular Diagnostics, Interest Area>Next Generation Bioetherapeutics, Interest Area>Partnering, Product Focus Zone/Special Pavilion>BIO Process Zone, Product Focus Zone/Special Pavilion>Contract Services Zone, Service>CMO, Session Tracks>Next Generation Biotherapeutics Sekisui Company Presentation
user-icon

Dr. Khatija Ali

BioSapien Inc

CEO

Brooklyn

United States

BioSapien Inc. Company Presentation
401550

Debbie Allen

arGEN-X

Senior Vice President Business Development

Zwijnaarde-Gent

Belgium

Interest Area>Autoimmune Disease, Interest Area>Biologics, Interest Area>CNS/Neurological, Interest Area>Hematology, Interest Area>Immune Disorder, Interest Area>Neurological Disease, Interest Area>Therapeutics Advanced Business Development Day 2
Allgood-Chalkboard-sqr

Brandon Allgood

Numerate

CTO

San Francisco

United States

Interest Area>Brain Health, Interest Area>CNS/Neurological, Interest Area>Cardiovascular, Interest Area>Genomics, Interest Area>Inflammatory Disease, Interest Area>Neurological Disease, Interest Area>Renal, Interest Area>Small Molecules, Interest Area>Therapeutics, Interest Area>Translational Research, Session Tracks>Brain Health, Session Tracks>Digital Health, Session Tracks>Translational Research The Hype, the Promise and the Reality of Artificial Intelligence in Personalized Medicine
user-icon

Niva Almaula

Actinium Pharmaceuticals, Inc.

Chief Business Officer

New York

United States

Actinium Pharmaceuticals, Inc. Company Presentation